Describe the latest procedural technologies to address benign prostatic hyperplasia (BPH), focusing on patient selection, minimally-invasive therapies, and treatment options
Assess the diagnosis and treatment of overactive bladder (OAB), contrasting currently available agents and treatment methods
Review effective strategies for management of general urologic health conditions such as Peyronie’s disease, incontinence, penile implant surgery, stress urinary incontinence (SUI), and other LUTS conditions
Describe the treatment of bladder cancer from NMIBC to MIBC
Assess novel imaging and treatments for renal cell mass characterization
Describe the latest imaging and treatment options for prostate cancer including PET radiopharmaceuticals, including PSMA PET, novel androgen pathway inhibitors, immunotherapies, radiopharmaceuticals, PARP inhibitors, and radioligand therapy
